FAU own research funding: EFI / IZKF / EAM ...
Start date : 01.06.2021
End date : 31.05.2022
Extension date: 30.11.2023
Diagnosis of the rare neurodegenerative disease multisystem atrophy (MSA) is hampered by a lack of biomarkers. We could show that in an MSA mouse model, a myelin deficit can be visualized by quant. susceptibility mapping (QSM)on MRI. Our preliminary clinical data show similar results. The aim is now to comprehensively assess QSM imaging as a biomarker for the differential diagnosis of neurodegenerative diseases.